Eli Lilly and Company EPS (Earnings per Share) 2007–2025
Eli Lilly and Company reported $22.95 of earnings per share for fiscal 2025. That was 96.0% higher than fiscal 2024. Compared with fiscal 2020, the change was +238.0%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $22.95 | +96.0% |
| FY 2024 | $11.71 | +101.9% |
| FY 2023 | $5.80 | -15.9% |
| FY 2022 | $6.90 | +12.7% |
| FY 2021 | $6.12 | -9.9% |
| FY 2020 | $6.79 | -23.6% |
| FY 2019 | $8.89 | +184.0% |
| FY 2018 | $3.13 | +1747.4% |
| FY 2017 | $-0.19 | -107.4% |
| FY 2016 | $2.58 | +14.2% |
| FY 2015 | $2.26 | +1.3% |
| FY 2014 | $2.23 | -48.4% |
| FY 2013 | $4.32 | +18.0% |
| FY 2012 | $3.66 | -6.2% |
| FY 2011 | $3.90 | -14.8% |
| FY 2010 | $4.58 | +16.2% |
| FY 2009 | $3.94 | +308.5% |
| FY 2008 | $-1.89 | — |
| FY 2007 | $0.00 | — |
Source: Eli Lilly and Company SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open LLY 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Eli Lilly and Company reported $22.95 of earnings per share for fiscal 2025. That was 96.0% higher than fiscal 2024. Compared with fiscal 2020, the change was +238.0%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Eli Lilly and Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeEli Lilly and Company — frequently asked questions
What is Eli Lilly and Company's earnings per share?
Eli Lilly and Company (LLY) reported earnings per share of $22.95 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Eli Lilly and Company's official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.